ASH 2015 highlights by Prof. Michael Hallek
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al.
Overview of Bruton's tyrosine kinase (BTK) inhibitors in chronic lymphocytic leukemia
Novel therapies in myeloma: selinexor, venetoclax, among others
Heinz Ludwig et al.
ROR1 and its role in CLL and other cancers
Thomas J. Kipps